Zoliflodacin demonstrated high microbiological cure rates for uncomplicated urogenital gonorrhea, with 90.9% efficacy in the general population. The trial was open-label and had limited representation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback